Market Tracker

10/20 4:45pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

8.68
Data as of Oct 20
 +0.24 / +2.84%
Today’s Change
2.05
Today|||52-Week Range
8.99
+62.82%
Year-to-Date

Today’s Trading

Previous close8.44
Today’s open8.34
Day’s range8.34 - 8.80
Volume1,814,583
Average volume (3 months)1,891,479
Market cap$882.7M
Dividend yield--
Data as of 3:59pm ET, 10/20/2014

Growth & Valuation

Earnings growth (last year)-5.32%
Earnings growth (this year)+33.33%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales11.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...+0.16+3.99%
SRPTSarepta Therapeutics...+0.61+2.75%
EPZMEpizyme Inc+0.48+1.77%
EBSEmergent BioSolution...-0.87-3.87%
Data as of 4:02pm ET, 10/20/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$47.8M
Annual profit (last year)-$130.9M
Net profit margin-273.98%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts